Changes in expression of vascular endothelial growth factor and its receptors in neonatal hypoxia-induced pulmonary hypertension

Pediatric Research

Volumn 58, Issue 2, 2005, Pages 199-205

  Nadeau, Sophie ^a   Baribeau, Johanne ^a   Janvier, Annie ^a   Perreault, Thérèse ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGENIC AGENT; NITRIC OXIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME IMMUNOASSAY; GENE EXPRESSION; ISOLATED LUNG; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEPTOR BINDING; TISSUE LEVEL; VASODILATATION; WESTERN BLOTTING;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOTTING, WESTERN; CYTOSOL; ENDOTHELIUM, VASCULAR; HYPERTENSION, PULMONARY; LIGANDS; LUNG; MUSCLE, SMOOTH; NITRIC OXIDE SYNTHASE; OXYGEN; PERFUSION; SWINE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASOCONSTRICTOR AGENTS;

EID: 23244443543     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000169969.18669.D2     Document Type: Article

References (42)

1. Breier G 2000 Functions of the VEGF/VEGF receptor system in the vascular system. Semin Thromb Hemost 26:553-559
2. Ferrara N 2001 Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol 280:C1358-C1366
3. Zachary I, Gliki G 2001 Signaling transduction mechanisms mediating biological actions of the endothelial growth factor family. Cardiovasc Res 49:568-581
4. Tuder RM, Flook BE, Voekel NF 1995 Increased gene expression for VEGF and the VEGF receptors KDR/flk in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439
6. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
7. Takahashi T, Shibuya M 1997 The 230-kDa mature form of KDR/flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079-2089
8. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT 1992 The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991
9. Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, Eddahibi S 2000 Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 23:762-771
10. Shen BQ, Lee DY, Zioncheck TF 1999 Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274:33057-33063
11. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ 1998 Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Fil-1. Mol Hum Reprod 4:377-386
12. Kendall RL, Thomas KA 1993 Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble factor. Proc Natl Acad Sci USA 90:10705-10709
13. Kendall RL, Wang G, Thomas KA 1996 Identification of a natural soluble form of vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328
14. Moss AJ, Emmanouilides G, Duffie ER Jr 1963 Closure of the ductus arteriosus in the newborn infant. Pediatrics 32:25-30
15. Kinsella JP, Abman SH 1995 Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126:853-864
16. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM 1976 Persistent pulmonary hypertension of the newborn. J Pediatr 89:626-630
17. Lassus P, Turanlahti M, Heikkilä P, Andersson LC, Nupponen I, Sarnesto A, Andersson S 2001 Pulmonary vascular endothelial growth factor and Fit-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164:1981-1987
18. Deleted in proof
19. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Manon G, Waltenberger J, Voekel NF, Tuder RM 2001 Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15:427-438
20. Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, Abman SH 2003 Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol 284:L508-L517
21. Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, Black SM 2003 Expression of VEGF and its receptors Fit-1 and Flk-1/KDR are altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 285:L222-L231
22. Le Cras TD, Markham NE, Tuder RB, Voelkel NF, Abman SH 2002 Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol 283:L555-L562
23. Berkenbosch JW, Baribeau J, Perreault T 2000 Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension. Am J Physiol 278:L276-L283
24. Gosselin R, Gutkowska J, Baribeau J, Perreault T 1997 Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet. Am J Physiol 273:L72-L79
25. Perreault T, Baribeau J, Gosselin R, Gutkowka J 1997 Reduced vasodilator response to ANF in hypoxia-induced pulmonary hypertension in the newborn piglet. Am J Physiol 273:L289-L295
26. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, Baribeau J 2001 TBC3711, an ETA receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 50:374-383
27. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S 1998 Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 18:768-776
28. Tuder RM, Flook BE, Voelkel NF 1995 Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807
29. Shehata SM, Mooi WJ, Okazaki T, El-Banna I, Sharma HS, Tibboel D 1999 Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax 54:427-431
30. Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM 1997 Crystal structure at 1.7Å resolution of VEGF in complex with domain 2 of the Fit-1 receptor. Cell 91:695-704
31. Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, Weich HA 2000 Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 80:443-454
32. Duval M, Bédard-Goulet S, Delisle C, Gratton JP 2003 Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cb1-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J Biol Chem 278:20091-20097
33. Kremer C, Breier G, Risau W, Plate KH 1997 Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 57:3852-3859
34. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, Zioncheck TF 1998 Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979-29985
35. Yan SF, Lu J, Zou YS, Kisiel W, Mackman N, Leitges M, Steinberg S, Pinsky D, Stern D 2000 Protein kinase C-β and oxygen deprivation. A novel Egr-1 dependent pathway for fibrin deposition in hypoxic vasculature. J Biol Chem 275:11921-11928
36. Janvier AF, Nadeau S, Baribeau J, Perreault T 2003 Vasodilation to vascular endothelial growth factor (VEGF) may involve a non-nitric oxide (NO), non-prostacyclin PG12) mechanism in the neonatal piglet pulmonary vasculature. Pediatr Res 53:432A
37. Grover TR, Zenge JP, Parker TA, Abman SH 2002 Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus. Pediatr Res 52:907-912
38. Kroll J, Waltenberger J 1998 VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252:743-746
39. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, Madri JA 2003 Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160:605-615
40. Skalli O, Vandekerckhove J, Gabbiani G 1987 Actin-isoform pattern as a marker of normal or pathological smooth-muscle and fibroblastic tissues. Differentiation 33:232-238
41. Kocher O, Gabbiani G 1986 Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening and culture. Differentiation 32:245-251
42. Clowes AW, Clowes MM, Kocher O, Ropraz P, Chaponnier C, Gabbiani G 1988 Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin. J Cell Biol 107:1939-1945